D-0854-2020 Class II Terminated
FDA drug recall D-0854-2020 was initiated by American Health Packaging on Dec 4, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Low out of specification results obtained during stability testing. The recall status is terminated (terminated Aug 4, 2022). Affected quantity: 973 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 19, 2020
- Initiation Date
- Dec 4, 2019
- Termination Date
- Aug 4, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 973 cartons
Product description
Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11
Reason for recall
Failed Dissolution Specifications: Low out of specification results obtained during stability testing.
Distribution pattern
Nationwide within the United States
Code information
Lot #:180276A, Exp date 02/29/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0854-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026